Tirzepatide and Semaglutide Improve Weight Loss, Cardiovascular Conditions, but Deemed Too Expensive
Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...
Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard ...
As health care costs continue to rise and the burden of chronic disease grows, data-driven insights will be essential in ...
Historical data show the prevalence of pulmonary arterial hypertension (PAH) in adult patients with congenital heart disease ...
The role of artificial intelligence, DataDerm, and telehealth in advancing dermatology care was discussed throughout the ...
These studies published in The American Journal of Managed Care® explored telehealth, care access, and patient experience ...
An early pilot trial suggests that combining atezolizumab (tecectriq) with rituximab (Rituxan), gemcitabine (gemzar) and ...
Mehmet Oz, MD, the nominee to lead CMS under the Trump administration, testified in a confirmation hearing before the Senate ...
Patients expressed concern that overreliance on artificial intelligence (AI) could lead to clinicians losing their skills, ...
A multidisciplinary approach, early diagnosis, and comprehensive caregiver education are crucial in effectively managing ...
The second Trump administration is expected to bring changes to Medicaid, Medicare Advantage, and the health insurance ...
National MS Education and Awareness Month is celebrated each year in the US in March, after having been launched in 2003 by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results